NAMPT and acute myeloid leukemia: Treatment with NAMPT inhibitors KPT-9274 (1.5 μM) or daporinad (2 and 5 μM) with metformin (1 mM) significantly increased apoptosis and reduced mitochondrial membrane potential in primary AML cells (Fig. 4i, j).